Wells Fargo & Company upgraded shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from an equal weight rating to an overweight rating in a research note published on Monday, MarketBeat.com reports. Wells Fargo & Company currently has $45.00 price target on the medical device company’s stock, up from their previous price target of $21.00. […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “overweight” rating restated by analysts at Piper Sandler in a report issued on Friday, Benzinga reports. They presently have a $50.00 price objective on the medical device company’s stock, up from their prior price objective of $35.00. Piper Sandler’s price target points to a […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Piper Sandler in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $50.00 price objective on the medical device company’s stock, up from their previous price objective of $35.00. Piper […]
Several analysts have recently updated their ratings and price targets for Tandem Diabetes Care (NASDAQ: TNDM): 4/25/2024 – Tandem Diabetes Care was upgraded by analysts at Leerink Partnrs from a “market perform” rating to an “outperform” rating. 4/25/2024 – Tandem Diabetes Care was upgraded by analysts at SVB Leerink LLC from a “market perform” rating […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report)’s share price gapped up prior to trading on Monday . The stock had previously closed at $35.24, but opened at $37.25. Tandem Diabetes Care shares last traded at $37.68, with a volume of 135,297 shares changing hands. Analysts Set New Price Targets Several equities analysts have […]